Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Breast Neoplasms 71Carcinoma, Non-Small-Cell Lung 69Multiple Myeloma 55Prostatic Neoplasms 54Colorectal Neoplasms 42Leukemia, Myeloid, Acute 39Neoplasms 38Melanoma 34Lymphoma 33Ovarian Neoplasms 30Lymphoma, Non-Hodgkin 29Lung Neoplasms 28Squamous Cell Carcinoma of Head and Neck 27Sarcoma 27Neoplasm Metastasis 25Carcinoma, Hepatocellular 24Pancreatic Neoplasms 23Endometrial Neoplasms 23Glioma 22Carcinoma, Renal Cell 22Lymphoma, Large B-Cell, Diffuse 21Hodgkin Disease 21Recurrence 20Leukemia, Lymphocytic, Chronic, B-Cell 20Head and Neck Neoplasms 20Urinary Bladder Neoplasms 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Myelodysplastic Syndromes 18Esophageal Neoplasms 17Hematologic Neoplasms 16

Interventions

merphos 1fludarabine phosphate 1Whole-Body Irradiation 1Thiotepa 1Tacrolimus 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Methotrexate 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Blastic Plasmacytoid Dendritic Cell Neoplasm × 30 days × Clear all
NCT02220985 2026-06-01

Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD

Fred Hutchinson Cancer Center

Phase 2 Completed
84 enrolled 22 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Blastic Plasmacytoid Dendritic Cell Neoplasm, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡